BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.37M | -2.81M | -1.10M | -1.91M | -3.92M |
| Total Depreciation and Amortization | 515.00K | 62.00K | 71.00K | 151.00K | -28.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.41M | 2.29M | -4.96M | 2.54M | 3.20M |
| Change in Net Operating Assets | 6.17M | -650.00K | 5.51M | -2.26M | -741.00K |
| Cash from Operations | -1.28M | -1.12M | -474.00K | -1.49M | -1.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 366.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 366.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 4.70M | 1.00K | 0.00 | 3.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 4.70M | 1.00K | 0.00 | 3.17M |
| Foreign Exchange rate Adjustments | 5.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -907.00K | 3.59M | -473.00K | -1.49M | 1.69M |